Siemens Healthineers is reporting strong results for the first quarter of its 2026 fiscal year, which ended December 31, 2025.
The company highlighted that despite tariffs and currency pressure, it experienced an overall comparable revenue growth of 3.8%.
Siemens Healthineers reported comparable revenue growth in imaging (5.7%) and precision therapy (5.9%). Diagnostics declined in comparable revenue by 3.1%. The company said this was mainly due to a structural change in the China region market environment.
These results confirm Siemens' expectations for a revenue growth of between 5% to 6% compared with the previous fiscal year, it said.
